Supplier News

Two SpotSee Products Receive AABB Standards Accreditation

July 26, 2024

The HemoTemp II Blood Bag Temperature Indicator, which is an FDA-approved medical device, and the HemoTemp II Activator both were given the “Standards-Compliant” seal.

Univercells and University of Pennsylvania Expand Agreement for Gene Therapy Program

July 25, 2024

Univercells and the University of Pennsylvania are expanding their collaboration to evaluate certain bioreactors with the aim to scale up gene therapy manufacturing.

Agilent Expands Biopharma Offerings with BIOVECTRA Acquisition

July 23, 2024

The addition of BIOVECTRA’s biologics capabilities to accelerate drug development and manufacturing will allow Agilent to expand its end-to-end offerings for biopharma services.

Kadimastem and Pluri Enter Cell Therapy Manufacturing Deal

July 20, 2024

PluriCDMO, Pluri's newly launched CDMO division, has been selected by Kadimastem to manufacture two novel cell therapy product candidates.

Thermo Fisher Scientific Expands Proteomics Services with Olink Acquisition

July 13, 2024

Thermo Fisher will add Olink to its Life Sciences Solutions business.

Cell-Free Protein Synthesis Technology to be Made More Accessible Through LenioBio and Labscoop Partnership

July 04, 2024

LenioBio and Labscoop's new strategic partnership is aimed at increasing access to scalable cell-free protein synthesis technology across North America.

Aurigene to Provide Cell Therapy Discovery Services to Edity to Support Clinical Development

July 02, 2024

This collaboration aims to support and accelerate clinical development of advanced and novel technologies.

Lantheus Acquires Rights to Life Molecular’s RM2 Targeting GRPR for Prostate and Breast Cancers

June 27, 2024

GRPR, or gastrin-releasing peptide receptor, is part of the bombesin G protein-coupled receptor family and has been found to be overexpressed in multiple cancers.

CDMOs Announce Strategic Partnership for Fully Integrated Manufacturing Solutions

June 25, 2024

The pairing of Abzena and Argonaut Manufacturing Services is the result of several years’ worth of collaborative work between the two companies.

Bora Pharmaceuticals Acquires Baltimore Manufacturing Facility from Emergent

June 21, 2024

The transaction, announced June 20, follows Bora’s purchase of Minnesota-based Upsher-Smith Laboratories earlier in 2024.